1. Home
  2. TWST vs WVE Comparison

TWST vs WVE Comparison

Compare TWST & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$44.88

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.59

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
WVE
Founded
2013
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.4B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
TWST
WVE
Price
$44.88
$12.59
Analyst Decision
Buy
Strong Buy
Analyst Count
8
15
Target Price
$48.75
$31.47
AVG Volume (30 Days)
1.0M
2.1M
Earning Date
05-04-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
N/A
N/A
Revenue
$376,572,000.00
$3,704,000.00
Revenue This Year
$18.89
N/A
Revenue Next Year
$15.28
$119.93
P/E Ratio
N/A
N/A
Revenue Growth
20.32
149.43
52 Week Low
$23.30
$5.28
52 Week High
$57.88
$21.73

Technical Indicators

Market Signals
Indicator
TWST
WVE
Relative Strength Index (RSI) 46.93 42.11
Support Level $42.89 $12.53
Resistance Level $45.76 $15.02
Average True Range (ATR) 2.59 0.82
MACD -0.79 -0.08
Stochastic Oscillator 29.27 6.46

Price Performance

Historical Comparison
TWST
WVE

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: